Source: Jennifer Shike, Farm Journal’s Pork, 18 November 2021, photo credit: University of Plymouth
Antimicrobial resistance is a “One Health” challenge that requires effort across both human and animal health sectors, said Patricia Turner, president of World Veterinary Association.
Developing 100 new vaccines by 2025 was one of 25 commitments made by the world’s largest animal health companies in the Roadmap to Reducing the Need for Antibiotics report that was first published in 2019 by HealthforAnimals.
In the past two years, animal health companies have invested billions in veterinary research and the development of 49 new vaccines as part of an industry-wide strategy to reduce the need for antibiotics, according to a recent progress report released in Belgium.
The recently developed vaccines offer increased protection against disease across many animal species including cattle, poultry, swine, fish as well as pets, the release said. It is a sign the industry is halfway towards its vaccine target with four more years to go.
“New vaccines are essential to reducing the risk of drug resistance developing by preventing diseases in animals that could otherwise lead to antibiotic treatment, such as salmonella, bovine respiratory disease and infectious bronchitis, and preserving vital medicines for both urgent human and animal use,” HealthforAnimals said in a release.
Read more
The South African Pork Producers’ Organisation (SAPPO) coordinates industry interventions and collaboratively manages risks in the value chain to enable the sustainability and profitability of pork producers in South Africa.
